tiprankstipranks
Trending News
More News >
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (DE:2TZ)
FRANKFURT:2TZ
Germany Market

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Financial Statements

Compare
0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Financial Overview

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's market cap is currently €3.62B. The company's EPS TTM is €; its P/E ratio is ―; Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 8.22B¥ 8.25B¥ 6.91B¥ 6.60B¥ 6.99B
Gross Profit¥ 3.62B¥ 3.29B¥ 2.76B¥ 2.58B¥ 2.95B
Operating Income¥ 1.10B¥ 980.05M¥ 866.68M¥ 785.18M¥ 759.02M
EBITDA¥ 1.26B¥ 1.11B¥ 991.28M¥ 878.91M¥ 846.19M
Net Income¥ 986.71M¥ 861.79M¥ 769.14M¥ 661.70M¥ 625.57M
Balance Sheet
Cash & Short-Term Investments¥ 2.19B¥ 2.88B¥ 2.28B¥ 1.99B¥ 1.52B
Total Assets¥ 10.23B¥ 10.16B¥ 9.07B¥ 8.28B¥ 7.84B
Total Debt¥ 325.58M¥ 257.91M¥ 33.17M¥ 32.71M¥ 33.67M
Net Debt¥ -1.80B¥ -2.62B¥ -2.25B¥ -1.95B¥ -1.45B
Total Liabilities¥ 3.58B¥ 3.61B¥ 2.55B¥ 2.33B¥ 2.32B
Stockholders' Equity¥ 6.60B¥ 6.52B¥ 6.36B¥ 5.81B¥ 5.39B
Cash Flow
Free Cash Flow¥ 547.56M¥ 569.34M¥ 695.45M¥ 482.26M¥ 289.87M
Operating Cash Flow¥ 688.49M¥ 677.25M¥ 852.40M¥ 671.42M¥ 495.49M
Investing Cash Flow¥ -568.91M--¥ 73.77M-
Financing Cash Flow¥ -833.77M----
Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Debt to Assets

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Cash Flow

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.